Skip to main content
. 2012 Jul 12;3(6):517–525. doi: 10.1111/j.2040-1124.2012.00226.x

Figure 1.

image

Disposition of patients in the 12‐week double‐blind study and 40‐week open‐label extension. AE, adverse event.